Tae Kyung KIM,Jung Won WOO,Joan Yoon Ji LEE,Young-Joo AHN,Ji-Eun CHA,Hyou Young RHIM,Woo Ick JANG
申请号：
US16329317
公开号：
US20190224281A1
申请日:
2017.08.30
申请国别(地区):
US
年份:
2019
代理人:
摘要：
A method for treating growth hormone deficiency, including administering a human growth hormone fusion protein (GX-H9). A method includes administering a pharmaceutical composition containing an hGH fusion protein (GX-H9) and a pharmaceutically acceptable carrier, wherein the fusion protein (GX-H9) is administered once a week at a dose of 0.4 to 1.6 mg per body weight kg of a pediatric patient, or administered once every two weeks at a dose of 0.8 to 3.2 mg per body weight kg of a pediatric patient.
